Overview
Also known as:
FDA & Trial Timeline
8 eventsJohns Hopkins Bloomberg School of Public Health — PHASE3
Al-Azhar University — PHASE2
Novartis Pharmaceuticals — PHASE2
Assiut University
University of Virginia
Vowst: FDA approved
to prevent the recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older following antibacterial treatment for recurrent CDI (rCDI)
Alinia: FDA approved
Treatment of diarrhea caused by Cryptosporidium parvum and Giardia lamblia
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
2 availableAmBisome
Treatment of patients with Cryptococcus species infections refractory to amphotericin B deoxycholate, or in patients where renal impairment or unacceptable toxicity precludes the use of amphotericin B…
Treatment of patients with Cryptococcus species infections refractory to amphotericin B deoxycholate, or in patients where renal impairment or unacceptable toxicity precludes the use of amphotericin B deoxycholate
Alinia
Treatment of diarrhea caused by Cryptosporidium parvum and Giardia lamblia
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesTravel Grants
No travel grants are currently matched to Cryptosporidiosis.
Community
No community posts yet. Be the first to share your experience with Cryptosporidiosis.
Start the conversation →Latest news about Cryptosporidiosis
No recent news articles for Cryptosporidiosis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Cryptosporidiosis
Are there clinical trials for Cryptosporidiosis?
Yes — 4 recruiting clinical trials are currently listed for Cryptosporidiosis on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Cryptosporidiosis?
16 specialists and care centers treating Cryptosporidiosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for Cryptosporidiosis?
1 patient support program are currently tracked on UniteRare for Cryptosporidiosis. See the treatments and support programs sections for copay assistance, eligibility, and contact details.